Nonlinear association between PD-L1 expression levels and the risk of postoperative recurrence in non-small cell lung cancer

Sci Rep. 2024 Jul 4;14(1):15369. doi: 10.1038/s41598-024-66463-6.

Abstract

Accurate prediction of postoperative recurrence is important for optimizing the treatment strategies for non-small cell lung cancer (NSCLC). Previous studies identified the PD-L1 expression in NSCLC as a risk factor for postoperative recurrence. This study aimed to examine the contribution of PD-L1 expression to predicting postoperative recurrence using machine learning. The clinical data of 647 patients with NSCLC who underwent surgical resection were collected and stratified into training (80%), validation (10%), and testing (10%) datasets. Machine learning models were trained on the training data using clinical parameters including PD-L1 expression. The top-performing model was assessed on the test data using the SHAP analysis and partial dependence plots to quantify the contribution of the PD-L1 expression. Multivariate Cox proportional hazards model was used to validate the association between PD-L1 expression and postoperative recurrence. The random forest model demonstrated the highest predictive performance with the SHAP analysis, highlighting PD-L1 expression as an important feature, and the multivariate Cox analysis indicated a significant increase in the risk of postoperative recurrence with each increment in PD-L1 expression. These findings suggest that variations in PD-L1 expression may provide valuable information for clinical decision-making regarding lung cancer treatment strategies.

Keywords: Machine learning; Multivariate Cox proportional hazard model; Non-small cell lung cancer; Random forest; Recurrence-free survival.

MeSH terms

  • Aged
  • B7-H1 Antigen* / genetics
  • B7-H1 Antigen* / metabolism
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Non-Small-Cell Lung* / metabolism
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Carcinoma, Non-Small-Cell Lung* / surgery
  • Female
  • Humans
  • Lung Neoplasms* / metabolism
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / surgery
  • Machine Learning
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local*
  • Postoperative Period
  • Prognosis
  • Proportional Hazards Models
  • Risk Factors

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Biomarkers, Tumor